CHCT
ACHAT TOTAL: 18 000 titres (~272 980,00 $ US)
- Insiders
- Dupuy David H., Hensley Robert Z
- Total bought
- $272,980
- Total sold
- —
- Last activity
- 2026-08-14
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-14
CHCT presents a near-insolvency profile with a current ratio of 0.17, interest coverage below 1.0, and a catastrophic gross margin collapse from ~80% to ~8.7%, making the financial foundation deeply unreliable.
The first sentence of the analysis written for CHCT on 2026-08-14 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 8.7% | 80.3% | 81.6% | 83.0% | 83.3% | |
| Ebit Margin | 32.3% | 17.7% | 22.9% | 34.7% | 36.7% | |
| Ebitda Margin | 68.2% | 55.5% | 58.7% | 68.7% | 71.1% | |
| Operating Profit Margin | 16.7% | 17.4% | 22.2% | 34.7% | 36.3% | |
| Pretax Profit Margin | 4.2% | -2.7% | 7.1% | 22.6% | 25.0% | |
| Continuous Operations Profit Margin | 4.2% | -2.7% | 6.8% | 22.5% | 24.8% | |
| Net Profit Margin | 4.2% | -2.7% | 6.8% | 22.5% | 24.8% | |
| Bottom Line Profit Margin | 1.7% | -5.2% | 4.5% | 19.6% | 22.3% | |
| Current Ratio | 0.170 | 0.250 | 5.743 | 4.392 | 1.975 | |
| Quick Ratio | 0.170 | 0.250 | 5.743 | 4.392 | 1.975 | |
| Solvency Ratio | 0.087 | 0.078 | 0.111 | 0.145 | 0.184 | |
| Cash Ratio | 0.012 | 0.019 | 0.285 | 0.738 | 0.099 | |
| Price To Earnings Ratio | 212.145 | -83.522 | 133.200 | 44.198 | 54.333 | |
| Price To Earnings Growth Ratio | -1.587 | 0.388 | -1.769 | -6.409 | 6.210 | |
| Forward Price To Earnings Growth Ratio | -1.587 | 0.388 | -1.769 | -6.409 | 6.210 | |
| Price To Earnings Diluted Ratio | 212.145 | -83.522 | 133.200 | 44.198 | 54.333 | |
| Price To Earnings Diluted Growth Ratio | -1.587 | 0.388 | -1.769 | -6.409 | 6.210 | |
| Price To Book Ratio | 1.027 | 1.071 | 1.308 | 1.703 | 2.380 | |
| Price To Sales Ratio | 3.639 | 4.402 | 5.950 | 8.661 | 12.140 | |
| Price To Free Cash Flow Ratio | 12.282 | 14.886 | 15.834 | 16.952 | 22.383 | |
| Price To Operating Cash Flow Ratio | 7.815 | 8.655 | 10.938 | 14.034 | 19.515 | |
| Debt To Assets Ratio | 0.541 | 0.494 | 0.436 | 0.407 | 0.357 | |
| Debt To Equity Ratio | 1.249 | 1.029 | 0.803 | 0.719 | 0.583 | |
| Debt To Capital Ratio | 0.555 | 0.507 | 0.445 | 0.418 | 0.368 | |
| Long Term Debt To Capital Ratio | 0.390 | 0.365 | 0.440 | 0.415 | 0.354 | |
| Financial Leverage Ratio | 2.307 | 2.085 | 1.842 | 1.764 | 1.632 | |
| Working Capital Turnover Ratio | -0.597 | -1.985 | 2.058 | 2.615 | 13.337 | |
| Operating Cash Flow Ratio | 0.202 | 0.253 | 5.019 | 3.958 | 2.384 | |
| Operating Cash Flow Sales Ratio | 0.466 | 0.509 | 0.544 | 0.617 | 0.622 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.636 | 0.581 | 0.691 | 0.828 | 0.872 | |
| Debt Service Coverage Ratio | 0.283 | 0.273 | 2.897 | 5.584 | 2.851 | |
| Interest Coverage Ratio | 0.595 | 0.849 | 1.411 | 2.852 | 3.122 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.219 | 0.278 | 12.353 | 427.518 | 4.696 | |
| Operating Cash Flow Coverage Ratio | 0.105 | 0.120 | 0.149 | 0.169 | 0.209 | |
| Capital Expenditure Coverage Ratio | 2.749 | 2.389 | 3.234 | 5.810 | 7.806 | |
| Dividend Paid And Capex Coverage Ratio | 0.761 | 0.771 | 0.916 | 1.099 | 1.135 | |
| Dividend Payout Ratio | 10.519 | -16.252 | 6.230 | 2.020 | 1.885 | |
| Enterprise Value Multiple | 11.774 | 15.495 | 16.304 | 17.755 | 21.213 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 8.7% | ▼-71.6% | ▼-58.7% |
| Ebit Margin | 32.3% | ▲14.6% | ▲3.5% |
| Ebitda Margin | 68.2% | ▲12.8% | ▲3.8% |
| Operating Profit Margin | 16.7% | ▼-0.7% | ▼-8.8% |
| Pretax Profit Margin | 4.2% | ▲7.0% | ▼-7.0% |
| Continuous Operations Profit Margin | 4.2% | ▲7.0% | ▼-6.9% |
| Net Profit Margin | 4.2% | ▲7.0% | ▼-6.9% |
| Bottom Line Profit Margin | 1.7% | ▲6.9% | ▼-6.9% |
| Current Ratio | 0.170 | ▼-0.080 | ▼-2.336 |
| Quick Ratio | 0.170 | ▼-0.080 | ▼-2.336 |
| Solvency Ratio | 0.087 | ▲0.008 | ▼-0.035 |
| Cash Ratio | 0.012 | ▼-0.007 | ▼-0.219 |
| Price To Earnings Ratio | 212.145 | ▲295.666 | ▲140.074 |
| Price To Earnings Growth Ratio | -1.587 | ▼-1.976 | ▼-0.954 |
| Forward Price To Earnings Growth Ratio | -1.587 | ▼-1.976 | ▼-0.954 |
| Price To Earnings Diluted Ratio | 212.145 | ▲295.666 | ▲140.074 |
| Price To Earnings Diluted Growth Ratio | -1.587 | ▼-1.976 | ▼-0.954 |
| Price To Book Ratio | 1.027 | ▼-0.044 | ▼-0.471 |
| Price To Sales Ratio | 3.639 | ▼-0.763 | ▼-3.320 |
| Price To Free Cash Flow Ratio | 12.282 | ▼-2.604 | ▼-4.185 |
| Price To Operating Cash Flow Ratio | 7.815 | ▼-0.841 | ▼-4.377 |
| Debt To Assets Ratio | 0.541 | ▲0.048 | ▲0.094 |
| Debt To Equity Ratio | 1.249 | ▲0.219 | ▲0.372 |
| Debt To Capital Ratio | 0.555 | ▲0.048 | ▲0.096 |
| Long Term Debt To Capital Ratio | 0.390 | ▲0.024 | ▼-0.003 |
| Financial Leverage Ratio | 2.307 | ▲0.222 | ▲0.381 |
| Working Capital Turnover Ratio | -0.597 | ▲1.388 | ▼-3.682 |
| Operating Cash Flow Ratio | 0.202 | ▼-0.051 | ▼-2.161 |
| Operating Cash Flow Sales Ratio | 0.466 | ▼-0.043 | ▼-0.086 |
| Free Cash Flow Operating Cash Flow Ratio | 0.636 | ▲0.055 | ▼-0.085 |
| Debt Service Coverage Ratio | 0.283 | ▲0.011 | ▼-2.094 |
| Interest Coverage Ratio | 0.595 | ▼-0.253 | ▼-1.171 |
| Short Term Operating Cash Flow Coverage Ratio | 0.219 | ▼-0.059 | ▼-88.794 |
| Operating Cash Flow Coverage Ratio | 0.105 | ▼-0.015 | ▼-0.045 |
| Capital Expenditure Coverage Ratio | 2.749 | ▲0.360 | ▼-1.648 |
| Dividend Paid And Capex Coverage Ratio | 0.761 | ▼-0.011 | ▼-0.176 |
| Dividend Payout Ratio | 10.519 | ▲26.771 | ▲9.639 |
| Enterprise Value Multiple | 11.774 | ▼-3.721 | ▼-4.734 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $441.0M | $509.6M | $671.4M | $846.0M | $1.10B | |
| Enterprise value | $973.8M | $995.2M | $1.08B | $1.19B | $1.37B | |
| EV / Sales | 8.04x | 8.60x | 9.57x | 12.20x | 15.09x | |
| EV / Op. cash flow | 17.26x | 16.90x | 17.60x | 19.77x | 24.25x | |
| EV / Free cash flow | 27.12x | 29.07x | 25.47x | 23.88x | 27.82x | |
| EV / EBITDA | 11.77x | 15.49x | 16.30x | 17.75x | 21.21x | |
| Net debt / EBITDA | 6.44x | 7.56x | 6.17x | 5.15x | 4.14x | |
| Current ratio | 0.17x | 0.25x | 5.74x | 4.39x | 1.98x | |
| Income quality | 11.06x | -18.51x | 7.96x | 2.74x | 2.50x | |
| Graham number | $8 | — | $12 | $21 | $21 | |
| Graham net-net | -$20 | -$18 | -$15 | -$14 | -$11 | |
| Tax burden | 99.6% | 100.0% | 96.2% | 99.8% | 99.3% | |
| Interest burden | 13.1% | -15.5% | 31.1% | 65.0% | 68.2% | |
| Working capital | -$231.5M | -$174.7M | $58.0M | $51.7M | $23.0M | |
| Invested capital | -$227.2M | -$169.6M | $913.3M | $57.4M | $26.3M | |
| Return on assets | 0.5% | -0.3% | 0.8% | 2.5% | 3.0% | |
| Operating ROA | 2.0% | 2.1% | 2.8% | 4.2% | 4.6% | |
| Return on tangible assets | 0.5% | -0.3% | 0.8% | 2.5% | 3.0% | |
| Return on equity | 1.2% | -0.7% | 1.5% | 4.4% | 4.9% | |
| Return on invested capital | 2.1% | 2.1% | 2.6% | 3.9% | 4.4% | |
| Return on capital employed | 2.8% | 2.6% | 2.7% | 3.9% | 4.5% | |
| Earnings yield | 1.2% | -0.6% | 1.1% | 2.6% | 2.0% | |
| Free cash flow yield | 8.1% | 6.7% | 6.3% | 5.9% | 4.5% | |
| Capex / Op. cash flow | 36.4% | 41.9% | 30.9% | 17.2% | 12.8% | |
| Capex / Depreciation | 47.1% | 57.6% | 46.9% | 31.3% | 23.1% | |
| Capex / Sales | 16.9% | 21.3% | 16.8% | 10.6% | 8.0% | |
| SG&A / Sales | 20.7% | 16.5% | 24.2% | 15.2% | 13.4% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 8.5% | 8.6% | 17.7% | 9.6% | 7.9% | |
| Intangibles / Total assets | 0.1% | 0.2% | 0.3% | 0.3% | 0.1% | |
| Days sales outstanding | 112d | 143d | 184d | 201d | 174d | |
| Days payables outstanding | 0d | 0d | 212d | 0d | 0d | |
| Operating cycle | 112d | 143d | 184d | 201d | 174d | |
| Cash conversion cycle | 112d | 143d | -28d | 201d | 174d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-13.5%EV / Sales ▼-6.5%EV / EBITDA ▼-24.0%EV / Op. cash flow ▲+0.355Earnings yield ▲+0.018
Profitability
Return on equity ▲+0.019Return on assets ▲+0.008Return on invested capital +0.000Return on capital employed ▲+0.002Operating ROA -0.000Income quality ▲+29.571Tax burden ▼-0.004
Efficiency
Days sales outstanding ▼-30.488Days payables outstanding n/aOperating cycle ▼-30.488Cash conversion cycle ▼-30.488Capex / Sales ▼-0.043R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.080Net debt / EBITDA ▼-1.118Working capital ▼-56826000.000Invested capital ▼-57541000.000Intangibles / Total assets ▼-0.001
Change over 5 years
Valuation
Market cap ▼-59.9%EV / Sales ▼-46.7%EV / EBITDA ▼-44.5%EV / Op. cash flow ▼-6.997Earnings yield ▼-0.009Graham number ▼-12.521
Profitability
Return on equity ▼-0.037Return on assets ▼-0.025Return on invested capital ▼-0.023Return on capital employed ▼-0.017Operating ROA ▼-0.026Income quality ▲+8.555Tax burden ▲+0.003
Efficiency
Days sales outstanding ▼-61.414Days payables outstanding n/aOperating cycle ▼-61.414Cash conversion cycle ▼-61.414Capex / Sales ▲+0.090R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-1.805Net debt / EBITDA ▲+2.297Working capital ▼-254558000.000Invested capital ▼-253485000.000Intangibles / Total assets ▲+0.001
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-10 Community Healthcare Trust Is Still Overvalued Community Healthcare Trust (CHCT) remains overvalued at $15.58, with fair value estimated at $12 per share based on true AFFO analysis. CHCT faces headwinds from high lease rollovers, lower property quality, and tenant retention issues, pressuring future same-store NOI and requiring substantial tenant improvements. Resolution of six troubled behavioral health facilities is progressing, but new leases will likely reduce NOI while stabilizing risk.
- 2026-08-06 Down 14.0% in 4 Weeks, Here''s Why Community Healthcare Trust (CHCT) Looks Ripe for a Turnaround Community Healthcare Trust (CHCT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 2026-08-06 Community Healthcare Trust: The Dividend Cut Creates A Buying Opportunity Community Healthcare Trust Incorporated is rated a ''buy'' following a 32% dividend cut, viewed as a prudent capital allocation decision. Retained earnings from the dividend cut, estimated at $25–$30 million, will fund accretive acquisitions, reinvestment, and occupancy improvements. CHCT''s Q2 FAD per share is $0.47, supporting a sustainable 68% payout ratio post-cut, compared to an unsustainable 100%+ previously.
- 2026-08-06 Community Healthcare Trust Q2 Earnings Call Highlights Community Healthcare Trust NYSE: CHCT outlined a strategic plan centered on retaining more capital for acquisitions, improving occupancy and recycling assets after reporting second-quarter adjusted funds from operations of $0.56 per diluted share, unchanged from the first quarter.
- 2026-08-05 Community Healthcare Trust Incorporated (CHCT) Q2 2026 Earnings Call Transcript Community Healthcare Trust Incorporated (CHCT) Q2 2026 Earnings Call Transcript
- 2026-08-05 Is Community Healthcare Trust (CHCT) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 2026-08-05 Arrowstreet Capital Limited Partnership Sells 54,631 Shares of Community Healthcare Trust Incorporated $CHCT Arrowstreet Capital Limited Partnership trimmed its position in Community Healthcare Trust Incorporated (NYSE: CHCT) by 20.8% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 208,588 shares of the real estate investment trust''s stock after selling 54,631 shares
- 2026-08-04 Community Healthcare Trust (CHCT) Q2 FFO and Revenues Miss Estimates Community Healthcare Trust (CHCT) came out with quarterly funds from operations (FFO) of $0.56 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to FFO of $0.5 per share a year ago.
- 2026-08-04 Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026 FRANKLIN, Tenn., Aug. 4, 2026 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) (the "Company") today announced results for the three months ended June 30, 2026.
- 2026-07-31 Wall Street Loves These 3 High-Yield Stocks Ahead of August High-yield picks like CHCT, LGGNY and NLY stand out as resilient income options as investors navigate inflation, rate uncertainty and market volatility.